Good Employers Keep Choosing the Wrong PBM Because They Start With the Wrong Metrics
Employers still rely too heavily on discounts and rebates to shortlist Pharmacy Benefit Managers (PBMs), according to US …
How to Judge a PR Effort by Credibility, Not Clip Count
Clip counts don’t close deals. You’ve seen the endless reports filled with media mentions that don’t move the needle. Wh …
Trace3 Says AI's Production Gap Is Not a Technology Problem
As AI moves from pilots into production, Trace3 says the real test is no longer whether the technology works, but whethe …
Insurance Coverage Doesn't Guarantee Medication Access, SHARx Says
Prior authorizations, formulary exclusions, step therapy, and specialty pharmacy restrictions can delay treatment even w …
AI in the Courtroom Is Becoming a Malpractice Risk for Law Firms, Wisner Baum Warns
With AI hallucinations increasingly showing up in legal filings, law firms face a new professional responsibility challe …
The $10B TAVR Market Grew. Why Are Most Patients Still Untreated?
After decades of device-delivery progress, the next era of TAVR must be judged by valve design, physiologic blood flow, …
What Disruptive Companies Should Measure Instead of Impressions to Earn Real Market Influence
Impressions have long been the go-to metric in PR, but they don’t tell the real story. You can rack up millions of eyeba …
Breaker Partners With PatternIQ to Power Newsletter Monetization
With U.S. digital ad revenue reaching $258.6 billion in 2024 and global ad revenue projected to top $1 trillion in 2025, …
The Webinar Is the New Content Engine (But Most Brands Still Underuse It)
As marketing teams face growing pressure to do more with less, Riverside is challenging the outdated webinar model built …
